JMJD2B (KDM4B) Homogenous Assay Kit
The JMJD2B (KDM4B) Homogeneous Assay Kit is designed to measure JMJD2B (Jumonji domain-containing protein 2B) activity for screening and profiling applications. The JMJD2B (KDM4B) Homogeneous Assay Kit comes in a convenient 96-well or 384-well AlphaLISA® format, with enough purified recombinant JMJD2B (amino acids 2-500), substrate, primary antibody, assay and detection buffer for 100 or 400 enzyme reactions.
Figure 1: JMJD2B (KDM4B) Homogenous Assay Kit schematic.
A sample containing JMJD2B is incubated with a substrate. This is followed by the addition of acceptor beads and primary antibody, and finally donor beads. Alpha-counts are then counted. Alpha-counts are proportional to JMJD2B demethylase activity.
Need us to run inhibitor screens or profile your compounds against JMJD2B (KDM4B)? Check out our Demethylase Screening Services.
- AlphaLISA® anti-mouse IgG acceptor beads, 5 mg/ml (PerkinElmer #AL105C)
- AlphaScreen® Streptavidin-conjugated donor beads, 5 mg/ml (PerkinElmer #6760002S)
- Optiplate -96 or -384 (PerkinElmer #6005290)
- AlphaScreen® microplate reader
96 reactions
Catalog # | Name | Amount | Storage |
50111 | JMJD2B (KDM4B), GST-Tag* | 10 µg | -80°C |
52140E | Primary Antibody 5 | 5 µl | -80°C |
79841 | Biotinylated Histone H3 Peptide Substrate | 300 reactions | -80°C |
52407 | 4x HDM Assay Buffer 2 | 3 x 1 ml | -80°C |
52301 | 4x Detection Buffer | 2 ml | -20°C |
*The initial concentration of enzyme is lot-specific and will be indicated on the tube containing the protein.
384 reactions
Catalog # | Name | Amount | Storage |
50111 | JMJD2B (KDM4B), GST-Tag* | 60 µg | -80°C |
52140E | Primary Antibody 5 | 20 µl | -80°C |
79841 | Biotinylated Histone H3 Peptide Substrate | 500 reactions | -80°C |
52407 | 4x HDM Assay Buffer 2 | 3 x 1 ml | -80°C |
52301 | 4x Detection Buffer | 2 ml | -20°C |
*The initial concentration of enzyme is lot-specific and will be indicated on the tube containing the protein.
JMJD2B (Jumonji domain -containing protein 2B), also known as KDM4B, belongs to the JMJD2 subfamily of JMJD histone lysine demethylase proteins. It is involved in demethylating H3K9me2/3, thus participating in osteogenic differentiation of mesenchymal stem cells, regulation of transcription for maintenance of trophoblast stem cells, DNA damage response (DDR), cell cycle progression and apoptosis. JMJD2B is found at high levels in different cancer types, such as breast, gastric and colorectal cancer and Hodgin’s lymphoma, and also during inflammation. JMJD2B is regulated by HIF1α (hypoxia-inducible factor 1 alpha), and silencing JMJD2B in colorectal cancer cells can stimulate DDR responses and inhibit cancer cell proliferation. The use of JMJD2B inhibitors is an area of interest that requires further development, and the development of active inhibitors will be beneficial in the cancer therapy field.
Manni W., et al., 2022 Signal Transduct Target Ther 7:304.
Mak K., et al., 2021 Scientific Reports 11:884.
Chen L., et al., 2014 British Journal of Cancer 110:1014-1026.